Published in Clin Infect Dis on July 27, 2006
Metabolic outcomes in a randomized trial of nucleoside, nonnucleoside and protease inhibitor-sparing regimens for initial HIV treatment. AIDS (2009) 2.91
Morphologic and metabolic abnormalities in vertically HIV-infected children and youth. AIDS (2009) 2.29
Obesity and dyslipidemia in behaviorally HIV-infected young women: Adolescent Trials Network study 021. Clin Infect Dis (2010) 1.11
Energy expenditure in HIV infection. Am J Clin Nutr (2011) 1.11
Current and Novel Inhibitors of HIV Protease. Viruses (2009) 1.10
Possible mitochondrial dysfunction and its association with antiretroviral therapy use in children perinatally infected with HIV. J Infect Dis (2010) 1.03
The role of protease inhibitors in the pathogenesis of HIV-associated lipodystrophy: cellular mechanisms and clinical implications. Toxicol Pathol (2009) 1.01
Management of the metabolic effects of HIV and HIV drugs. Nat Rev Endocrinol (2011) 0.97
Dysregulation of glucose metabolism in HIV patients: epidemiology, mechanisms, and management. Endocrine (2011) 0.96
Simplification strategies to reduce antiretroviral drug exposure: progress and prospects. Antivir Ther (2009) 0.96
Nutrition issues in chronic drug users living with HIV infection. Addict Sci Clin Pract (2009) 0.93
Dietary patterns and health and nutrition outcomes in men living with HIV infection. Am J Clin Nutr (2008) 0.85
Impact of antiretroviral therapy on lipid metabolism of human immunodeficiency virus-infected patients: Old and new drugs. World J Virol (2015) 0.84
The role of CCAAT enhancer-binding protein homologous protein in human immunodeficiency virus protease-inhibitor-induced hepatic lipotoxicity in mice. Hepatology (2013) 0.84
New and emerging agents in the management of lipodystrophy in HIV-infected patients. HIV AIDS (Auckl) (2010) 0.83
Improved measures of quality of life, lipid profile, and lipoatrophy after treatment interruption in HIV-infected patients with immune preservation: results of ACTG 5170. J Acquir Immune Defic Syndr (2008) 0.82
Lipodystrophy in HIV patients: its challenges and management approaches. HIV AIDS (Auckl) (2011) 0.81
A risk-factor guided approach to reducing lactic acidosis and hyperlactatemia in patients on antiretroviral therapy. PLoS One (2011) 0.80
HIV-associated lipodystrophy: a review from a Brazilian perspective. Ther Clin Risk Manag (2014) 0.78
Aging, human immunodeficiency virus, and bone health. Clin Interv Aging (2010) 0.78
Development of Buffalo Hump in the course of antiretroviral therapy including raltegravir and unboosted atazanavir: a case report and review of the literature. J Med Case Rep (2011) 0.77
Mid-ATR-FTIR spectroscopic profiling of HIV/AIDS sera for novel systems diagnostics in global health. OMICS (2014) 0.77
High-fat meals do not impair postprandial endothelial function in HIV-infected and uninfected men. AIDS Res Hum Retroviruses (2014) 0.75
The successful use of lipectomy in the management of airway obstruction in a woman with HIV-associated lipodystrophy. BMJ Case Rep (2015) 0.75
Pharmacogenetics as a tool to tailor antiretroviral therapy: A review. World J Virol (2015) 0.75
Oxazolidinones and human immunodeficiency virus. Antimicrob Agents Chemother (2007) 0.75
Alcoholic Extract of Lotus Leaves Improves Lipid Profile in Rats with HIV Protease Inhibitor-induced Dyslipidaemia. West Indian Med J (2015) 0.75
Growth hormone and tesamorelin in the management of HIV-associated lipodystrophy. HIV AIDS (Auckl) (2011) 0.75
New drugs approved in 2010. Proc (Bayl Univ Med Cent) (2011) 0.75
Cardiovascular, renal and liver events associated with human immunodeficiency virus type 1 infection and antiretroviral therapy. F1000 Med Rep (2009) 0.75
Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med (2000) 23.10
Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng (2001) 20.65
Characterization of an avian influenza A (H5N1) virus isolated from a child with a fatal respiratory illness. Science (1998) 19.40
Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature (1999) 12.95
Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat Med (2000) 8.89
A rare genotype of Cryptococcus gattii caused the cryptococcosis outbreak on Vancouver Island (British Columbia, Canada). Proc Natl Acad Sci U S A (2004) 6.21
Comparisons of highly virulent H5N1 influenza A viruses isolated from humans and chickens from Hong Kong. J Virol (1998) 5.48
TNF-dependent recruitment of the protein kinase RIP to the TNF receptor-1 signaling complex. Immunity (1996) 5.45
Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation. Mech Dev (2001) 4.47
Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol (1993) 4.08
An enzymatic activity in the yeast Sir2 protein that is essential for gene silencing. Cell (1999) 4.07
Effect of mobile phone intervention for diabetes on glycaemic control: a meta-analysis. Diabet Med (2011) 4.04
"Buffalo hump" in men with HIV-1 infection. Lancet (1998) 3.93
APC-mediated proteolysis of Ase1 and the morphogenesis of the mitotic spindle. Science (1997) 3.73
Prevalence and predictive value of intermittent viremia with combination hiv therapy. JAMA (2001) 3.73
Molecular mechanisms of myogenic coactivation by p300: direct interaction with the activation domain of MyoD and with the MADS box of MEF2C. Mol Cell Biol (1997) 3.62
Involvement of caspases in proteolytic cleavage of Alzheimer's amyloid-beta precursor protein and amyloidogenic A beta peptide formation. Cell (1999) 3.58
Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort. Neurology (2004) 3.44
Hybrid genotypes in the pathogenic yeast Cryptococcus neoformans. Microbiology (2001) 3.27
Effect of allelic heterogeneity on the power of the transmission disequilibrium test. Genet Epidemiol (2000) 3.24
Characterization of the surface proteins of influenza A (H5N1) viruses isolated from humans in 1997-1998. Virology (1999) 3.16
Low JAK2V617F allele burden in primary myelofibrosis, compared to either a higher allele burden or unmutated status, is associated with inferior overall and leukemia-free survival. Leukemia (2008) 3.04
Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med (1997) 3.03
Characterization of the cell-wall polysaccharides of Arabidopsis thaliana leaves. Plant Physiol (1995) 3.03
Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein. Proc Natl Acad Sci U S A (1998) 2.93
Guidelines for management of HIV infection with computer-based patient's record. Lancet (1995) 2.91
Drug susceptibility in HIV infection after viral rebound in patients receiving indinavir-containing regimens. JAMA (2000) 2.91
Activation of a phosphotyrosine phosphatase by tyrosine phosphorylation. Science (1993) 2.89
Heparin-induced oligomerization of FGF molecules is responsible for FGF receptor dimerization, activation, and cell proliferation. Cell (1994) 2.61
Sequence-based identification of Aspergillus, fusarium, and mucorales species in the clinical mycology laboratory: where are we and where should we go from here? J Clin Microbiol (2008) 2.57
The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J Cell Sci (1999) 2.55
Automated high resolution optical mapping using arrayed, fluid-fixed DNA molecules. Proc Natl Acad Sci U S A (1998) 2.50
Screening for extended-spectrum beta-lactamase-producing Enterobacteriaceae among high-risk patients and rates of subsequent bacteremia. Clin Infect Dis (2007) 2.49
Deficiency of T2K leads to apoptotic liver degeneration and impaired NF-kappaB-dependent gene transcription. EMBO J (2000) 2.48
Molecular cloning and characterization of retinal photoreceptor guanylyl cyclase-activating protein. Neuron (1994) 2.47
Bacteroides fragilis enterotoxin cleaves the zonula adherens protein, E-cadherin. Proc Natl Acad Sci U S A (1998) 2.45
Analysis of the interaction of FtsZ with itself, GTP, and FtsA. J Bacteriol (1997) 2.41
Physical activity levels in patients on hemodialysis and healthy sedentary controls. Kidney Int (2000) 2.40
The role of inherited TPMT and COMT genetic variation in cisplatin-induced ototoxicity in children with cancer. Clin Pharmacol Ther (2013) 2.40
Alternatives to HIV-1 RNA concentration and CD4 count to predict mortality in HIV-1-infected children in resource-poor settings. Lancet (2003) 2.38
The essential role of MEKK3 in TNF-induced NF-kappaB activation. Nat Immunol (2001) 2.32
Polyglutamine-expanded ataxin-7 antagonizes CRX function and induces cone-rod dystrophy in a mouse model of SCA7. Neuron (2001) 2.29
Src tyrosine kinase is a novel direct effector of G proteins. Cell (2000) 2.26
An oligodendrocyte cell adhesion molecule at the site of assembly of the paranodal axo-glial junction. J Cell Biol (2000) 2.24
Mental Health Law of the People's Republic of China (English translation with annotations): Translated and annotated version of China's new Mental Health Law. Shanghai Arch Psychiatry (2012) 2.22
Molecular evidence that the asexual industrial fungus Trichoderma reesei is a clonal derivative of the ascomycete Hypocrea jecorina. Proc Natl Acad Sci U S A (1996) 2.21
Disrupted signaling and inhibited regeneration in obese mice with fatty livers: implications for nonalcoholic fatty liver disease pathophysiology. Hepatology (2001) 2.14
Measurement of de novo hepatic lipogenesis in humans using stable isotopes. J Clin Invest (1991) 2.11
Fluconazole-resistant Candida albicans. Clin Infect Dis (1993) 2.10
Adherence of human immunodeficiency virus-infected patients to antiretroviral therapy. Clin Infect Dis (1999) 2.05
Intracranial dural arteriovenous fistulas: classification, imaging findings, and treatment. AJNR Am J Neuroradiol (2012) 2.00
High-risk behaviors during incarceration in African-American men treated for HIV at three Los Angeles public medical centers. J Acquir Immune Defic Syndr (2000) 2.00
Well-established nucleon resonances revisited by double-polarization measurements. Phys Rev Lett (2012) 1.99
Purification of recombinant adeno-associated virus vectors by column chromatography and its performance in vivo. Hum Gene Ther (2000) 1.97
Molecular karyotyping using an SNP array for genomewide genotyping. J Med Genet (2004) 1.95
Structural plasticity in the Drosophila brain. J Neurosci (1995) 1.92
A multicenter trial of selegiline transdermal system for HIV-associated cognitive impairment. Neurology (2007) 1.90
Metabolic effects of indinavir in healthy HIV-seronegative men. AIDS (2001) 1.90
Maintenance antiretroviral therapies in HIV infected patients with undetectable plasma HIV RNA after triple-drug therapy. AIDS Clinical Trials Group Study 343 Team. N Engl J Med (1998) 1.88
A precision measurement of the mass of the top quark. Nature (2004) 1.87
The effects of recombinant human growth hormone on body composition and glucose metabolism in HIV-infected patients with fat accumulation. J Clin Endocrinol Metab (2001) 1.86
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A (2001) 1.84
THE ADVISABILITY OF TOTALLY EXCISING BOTH PECTORAL MUSCLES IN THE RADICAL OPERATION FOR CANCER OF THE BREAST. Ann Surg (1918) 1.84
A redox-based O2 sensor in rat pulmonary vasculature. Circ Res (1993) 1.83
Transforming growth factor(beta)-mediated corneal myofibroblast differentiation requires actin and fibronectin assembly. Invest Ophthalmol Vis Sci (1999) 1.83
Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol (1996) 1.83
Power to detect linkage based on multiple sets of data in the presence of locus heterogeneity: comparative evaluation of model-based linkage methods for affected sib pair data. Hum Hered (2001) 1.82
Visual cycle impairment in cellular retinaldehyde binding protein (CRALBP) knockout mice results in delayed dark adaptation. Neuron (2001) 1.81
Regularized estimation for the accelerated failure time model. Biometrics (2009) 1.80
AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol (1997) 1.78
A new semiautomatic method for quantitative static and dynamic bone histology. Calcif Tissue Int (1982) 1.78
Age, apolipoprotein E4, and the risk of HIV dementia: the Hawaii Aging with HIV Cohort. J Neuroimmunol (2004) 1.78
Cell death attenuation by 'Usurpin', a mammalian DED-caspase homologue that precludes caspase-8 recruitment and activation by the CD-95 (Fas, APO-1) receptor complex. Cell Death Differ (1998) 1.76
Genome variation in Cryptococcus gattii, an emerging pathogen of immunocompetent hosts. MBio (2011) 1.76
The skin of domestic mammals as a model for the human skin, with special reference to the domestic pig. Curr Probl Dermatol (1978) 1.74
Pravastatin sodium activates endothelial nitric oxide synthase independent of its cholesterol-lowering actions. J Am Coll Cardiol (1999) 1.74
The use of a sensitive equilibrium dialysis method for the measurement of free testosterone levels in healthy, cycling women and in human immunodeficiency virus-infected women. J Clin Endocrinol Metab (1998) 1.71
Role of the proteasome and NF-kappaB in streptococcal cell wall-induced polyarthritis. Proc Natl Acad Sci U S A (1998) 1.69
Consistency of predictive signature genes and classifiers generated using different microarray platforms. Pharmacogenomics J (2010) 1.69
Clinical and pathologic evaluation of chronic Bartonella henselae or Bartonella clarridgeiae infection in cats. J Clin Microbiol (1999) 1.68
Young maternal age and parity. Influences on pregnancy outcome. Ann Epidemiol (1992) 1.68
Identification of clinical strains of Candida albicans by DNA fingerprinting with the polymerase chain reaction. Mycoses (1994) 1.67
A score-statistic approach for the mapping of quantitative-trait loci with sibships of arbitrary size. Am J Hum Genet (2001) 1.67
Molecular characterization of a novel short-chain dehydrogenase/reductase that reduces all-trans-retinal. J Biol Chem (1998) 1.66
Concordance of clinical and environmental isolates of Cryptococcus neoformans var. gattii by random amplification of polymorphic DNA analysis and PCR fingerprinting. J Clin Microbiol (1996) 1.63
Iron oxide nanoparticle platform for biomedical applications. Curr Med Chem (2009) 1.63
Assessing the non-motor symptoms of Parkinson's disease: MDS-UPDRS and NMS Scale. Eur J Neurol (2013) 1.61
Insulin resistance in HIV protease inhibitor-associated diabetes. J Acquir Immune Defic Syndr (1999) 1.61
Bartonella vinsonii subsp. berkhoffii and related members of the alpha subdivision of the Proteobacteria in dogs with cardiac arrhythmias, endocarditis, or myocarditis. J Clin Microbiol (1999) 1.59
Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol (1998) 1.58
A study examining inter- and intrarater reliability of three scales for measuring severity of psoriasis: Psoriasis Area and Severity Index, Physician's Global Assessment and Lattice System Physician's Global Assessment. Br J Dermatol (2006) 1.58
Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem (1995) 1.58
Rac1 inhibits TNF-alpha-induced endothelial cell apoptosis: dual regulation by reactive oxygen species. FASEB J (2000) 1.58
An approach to proteomic analysis of human tumors. Mol Carcinog (2000) 1.57
Cortactin underpins CD44-promoted invasion and adhesion of breast cancer cells to bone marrow endothelial cells. Oncogene (2006) 1.56
Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA (1999) 1.56
Toxoplasma encephalitis in patients with acquired immune deficiency syndrome: diagnosis and response to therapy. Am J Trop Med Hyg (1987) 1.56
Platelet-activating factor: a candidate human immunodeficiency virus type 1-induced neurotoxin. J Virol (1994) 1.56
Peer-delivered interventions reduce HIV risk behaviors among out-of-treatment drug abusers. Public Health Rep (1998) 1.55